The below sections are currently under review due to the Immunization RedesignIf you have questions or need information, please contact us |
---|
This content is designed for use when populating an immunization history when the client and/or provider do not have the detail of the trade name of the agent administered OR the product has been discontinued and/or never licensed in Canada. It consists mainly of concepts from the Medicinal Entity class and from the SNOMED CT Pharmaceutical / biologic product hierarchy that are described using a “generic name”. With time, concepts represented by the trade name may be found in this subset when they are no longer in use in Canada, but are required to capture historic data.
The scope of this subset is passive immunizing agents used in Canada (generically described, i.e. without trade name), those obtained through special access programs (generically described), and agents that have been discontinued and/or never licensed in Canada (with trade name). This content is intended to be used when populating an immunization history when the client and/or provider does not have the detail of the trade name of the agent administered OR the product has been discontinued and/or never licensed in Canada. This subset will include concepts represented by a generic description for an agent that was previously administered to the client as may be expressed by the client or provider for an immunization history and concepts represented by the trade name for products that have been discontinued and/or never licensed in Canada.
The format for the Fully Specified Name (FSN) is as follows:
A. For generic concepts
Passive Agent Name (product)
E.g.: Botulism antitoxin (product)
E.g.: Varicella-zoster immune globulin (product)
For example: Palivizumab (product)
For example: Human immunoglobulin product (product) vs Cytomegalovirus immune globulin (product)
For example: Rabies immune globulin (human) (product)
B. For concepts that include a Trade Name
Refer to the VaccineAdministeredTradeNameCode subset, Fully Specified Name section
Note: There is no Passive agent trade name product currently in this subset.
The format for the Preferred Synonym (P) is as follows:
A. For generic concepts
PHAC/CHI Product Abbreviation Passive Agent Name unspecified
E.g.: BAtx botulism antitoxin unspecified
B. For concepts that include a Trade Name
Refer to the VaccineAdministeredTradeNameCode subset, Preferred Synonym section
Note: There is no Passive Agent trade name product currently in this subset.